HIV 1 News and Research

RSS

Go-ahead for HIV computer game

A ground breaking computer game developed by a University of Salford lecturer to help educate young South Africans about the dangers of HIV and AIDS will be piloted in July.

1 Jun 2005

HIV deaths drop 90 percent among African-American IDUs who are given access to combination drug therapy

Combination drug therapy effectively reduces 90 percent of HIV deaths in African-American injection drug users when they are given ample access to care, according to a new Academy study in the June issue of the American Journal of Epidemiology.

1 Jun 2005

Study of compassionate care

Patients approaching the end of life can significantly reduce their depression symptoms and improve their sense of spiritual well-being according to a study published in the current issue of the Journal of Palliative Medicine.

1 Jun 2005

Interaction between cell and virus provides scientists valuable insights into the development of safe viral vectors for use in oncology

When infected by a virus, a cell uses specific defense mechanisms developed in the course of a long evolution. Thus, it can activate enzymes that disrupt or prevent replication of the viruses within the cell.

1 Jun 2005

African HIV subtypes identified in Minnesota

Public health researchers in Minnesota recently identified 83 persons infected with subtypes of HIV-1 that are not common in the United States, according to a report published in the June 15 issue of The Journal of Infectious Diseases, now available online.

31 May 2005

Over 3,000 lives lost because of blood bungle by Canadian Red Cross

The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.

31 May 2005

Survey shows sexual health important component of overall well being for midlife and beyond

Sexual health is an essential element of the quality of life of adults 45+. AARP's recent study, Sexuality at Midlife and Beyond, updates an AARP survey from 1999, and confirms that relationships and sexuality remain at least as important, if not more so, than almost six years ago.

30 May 2005

Ranbaxy makes further three filings of its Anti-Retroviral (ARVs) formulations

Ranbaxy Laboratories Limited has announced that the Company has made further three filings of its Anti-Retroviral (ARVs) formulations, to the World Health Organization (WHO) for its approval under the latter's pre-qualification project for HIV/AIDS drugs.

30 May 2005

Flavonols in food, key to healthy eating?

University of Melbourne scientists may have found the secret of the fresh fruit and vegetables centred ‘Mediterranean diet’.

29 May 2005

Doubts cast over India's AIDS figures

A controversy has erupted after Indian health workers have, expressed doubts over the new HIV/AIDS figures released by the government, they says the figures are too good to be true.

29 May 2005

Bill Clinton urges U.S. drug companies to be more flexible on generic drugs

Bill Clinton, the former U.S. president, is urging the United States to be more flexible in allowing money pledged for AIDS prevention to be used for low-cost generic drugs, and he has criticized U.S. drug manufacturers for pressuring the government to restrict use of those funds.

26 May 2005

Long-term perspective on the detection and identification of infectious diseases

A review of the history of infectious diseases commissioned by the Government is to be carried out by The University of Manchester.

From The University of Manchester 26 May 2005

Clinton Foundation aims to treat two million people with HIV in India by 2008

Former United States President Bill Clinton announced in India this week that his Foundation plans to train 150,000 private sector doctors for care and treatment.

26 May 2005

Research provides roadmap for the development of human therapies for cytomegalovirus (CMV)

McGill University Health Centre (MUHC) researchers have defined genetic resistance to the widespread virus, cytomegalovirus (CMV)--a member of the viral group that causes some of the world's most prevalent diseases, such as herpes, chicken pox and mononucleosis.

26 May 2005

Immediate treatment after suspected HIV transmission may do more harm than good

The active promotion of immediate treatment after suspected HIV transmission to minimise the risk of infection may be doing more harm than good, claim senior doctors in Sexually Transmitted Infections.

25 May 2005

India says HIV infections' on the decrease

India, which has the second highest number of HIV-infected people, says its awareness drive is getting through and says it has seen a dramatic slowdown in the number of new infections.

25 May 2005

Patients approaching the end of life can significantly reduce their depression symptoms and improve their sense of spiritual well-being

"Patients with serious medical conditions frequently suffer psychological, relational, and spiritual distress that is being inadequately addressed by modern health care," writes first author Douglas Miller, M.D., Indiana University School of Medicine professor of medicine, Regenstrief Institute, Inc. research scientist, and associate director of the IU Center for Aging Research.

25 May 2005

Guyana Health Minister outlines progress at World Health Assembly

Guyana Health Minister Dr. Leslie Ramsammy has outlined health progress being made in his country despite high levels of poverty and major floods that affected hundreds of thousands of people earlier this year.

23 May 2005

New hope for people with hepatitis C

University of New South Wales (UNSW) researchers are running two new studies on hepatitis C, which could revolutionise treatment for the virus.

22 May 2005

FDA recommends approval of the investigational anti-HIV drug tipranavir

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee recommended the approval of the investigational anti-HIV drug tipranavir (11-3). Tipranavir is a non-peptidic protease inhibitor that requires boosting with low-dose ritonavir and must be used in combination with other antiretroviral agents.

20 May 2005